tradingkey.logo

Inogen Inc

INGN
View Detailed Chart
5.660USD
0.0000.00%
Close 02/06, 16:00ETQuotes delayed by 15 min
153.66MMarket Cap
LossP/E TTM

Inogen Inc

5.660
0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

-4.07%

1 Month

-16.64%

6 Months

-10.16%

Year to Date

-15.77%

1 Year

-47.79%

View Detailed Chart

TradingKey Stock Score of Inogen Inc

Currency: USD Updated: 2026-02-06

Key Insights

Inogen Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 65 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 13.00.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Inogen Inc's Score

Industry at a Glance

Industry Ranking
65 / 205
Overall Ranking
175 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Inogen Inc Highlights

StrengthsRisks
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
Fairly Valued
The company’s latest PE is -5.65, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 19.79M shares, decreasing 18.29% quarter-over-quarter.
Held by Paul Tudor Jones
Star Investor Paul Tudor Jones holds 137.65K shares of this stock.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
13.000
Target Price
+129.68%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Inogen Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Inogen Inc Info

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
Ticker SymbolINGN
CompanyInogen Inc
CEOSmith (Kevin R. M)
Websitehttps://www.inogen.com/
KeyAI